Law For Drugs On Rebates

Original Language Title: Law on rebates for drugs

Subscribe to a Global-Regulation Premium Membership Today!

Key Benefits:

Subscribe Now for only USD$40 per month, or Get a Day Pass for only USD$9.99.

medicines discounts act

unofficial table of contents

AMRabG

date of delivery: 22.12.2010

full quote:

" The medicine discounts act of 22. December 2010 (BGBl. 2262, 2275), as defined by Article 3a of the Law of 7. August 2013 (BGBl. I p. 3108) "

:as amended by Art. 3a G v. 7.8.2013 I 3108

For details, see Notes

Footnote

(+ + + Text evidence from: 1.1.2011 + + +)

The G was referred to as Article 11a of the G v. 22.12.2010 I 2262 adopted by the Bundestag. It's gem. Article 12 (1) of this Act entered into force on 1 January 2011. Non-official table of contents

§ 1 Claim for Deposits

The pharmaceutical companies have the private health insurance company and the Carriers of the costs in sickness, care and birth cases according to the law of the civil service for prescription-only medicinal products, the costs of which have been reimbursed in whole or in part, according to the percentage of the cost of the charges corresponding to the costs. § 130a (1), (1a), (2), (3), (3a) and (3b) of the Fifth Book of the Social Code. This also applies to other carriers of costs in cases of illness, which bear these in the context of a protection in the event of illness, by means of which an insurance obligation pursuant to § 193 (3) sentence 1 of the Insurance Contract Law and in accordance with § 5 (1) Number 13 of the Fifth Book of the Social Code is excluded. For the purpose of determining the deductises as set out in the first sentence, any self-or self-content that has been agreed upon by companies of private health insurance with the policyholders or which are based on civil servants ' legal provisions or other provisions shall not be shall be considered. The deductions provided for in the first sentence may be used by the private health insurance companies exclusively to avoid or limit premium increases or to reduce the premium on the insurance holdings. Non-official table of contents

§ 2 Proof

The companies of the private health insurance and the carriers of the costs in sickness, care and care In the case of the private health insurance association, the association of private health insurance is a central body charged with the withdrawal of the surcharges. For the purpose of proof of the abatement, the central office or a body responsible for the assessment shall send the pharmaceutical central number of the medicinal product concerned, the date of delivery, the pharmacy identification mark and the proportion of the cost of the product to the pharmaceutical entrepreneurs. The pharmaceutical companies shall reimburse the charges within ten days after the claim has been made. The costs of sickness, care and birth costs in accordance with the rules of civil service law and the association of private health insurance may be borne by the leading organisations of the leading organisations of the For pharmaceutical companies, further details of the settlement and the payment period may also be agreed by way of derogation from this law. Other carriers according to § 1 sentence 2 shall be entitled to carry out the settlement of the charges either themselves or to have them carried out by the central body with appropriate participation at the costs. They may accede to the agreements referred to in the fourth sentence. Non-official table of contents

§ 3 Examination by trustee

The pharmaceutical companies may, in justified cases, and in random samples, To check the settlement of the charges by a trustee. For this purpose, the personal data required for the purpose of the examination may be transmitted to the trustee. Reproductions of digitised regulation sheets may also be submitted for proof. The trustee shall process and use the data transmitted to him only for the purpose of checking the billing of the charges. Further details of the examination may be provided in the agreement according to § 2 sentence 4. Non-official table of contents

§ 4 Information on the prescription sheet

In the case of the supply of medicinal products, which is the obligation to take a duty pursuant to Section 130a (1), (1a), 2, 3, 3a or 3b of the Fifth Book of the Social Code, to persons who do not receive them by way of the benefits of statutory health insurance, pharmacies, in addition to the dispensing price, have the pharmaceutical central number, the date of delivery and the Pharmacist labels shall be transferred in machine-readable form to this in the case of suitability of the regulation sheet. Further details may be provided by the institution of the costs in the case of sickness, care and birth cases in accordance with the provisions of civil service law and by the Association of Private Health Insurance, with the aid of the Top organization of pharmacists also deviate from this law. In particular, it may be agreed that pharmacies shall issue a receipt in machine-readable form via the pharmaceutical central number of the product dispensed, the purchase price and the delivery date. Other institutions according to § 1 sentence 2 may accede to the agreement in accordance with sentence 2. Non-official table of contents

§ 5 Data transfer by pharmaceutical entrepreneurs

The pharmaceutical companies are obligated to the necessary price and product information for medicinal products, including the cover of the association of private health insurance, and, upon request, the costs of sickness, care and birth costs in accordance with the rules of civil service law, to other carriers according to § 1, sentence 2, or to one or more places designated by them on machine-readable data carriers.